Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millipore Corporation and Gen-Probe have launched the first product from their collaboration to create faster, sensitive, more robust tests for detecting contaminants in pharmaceutical and biotechnology manufacturing processes.
Subscribe to our email newsletter
According to the companies, the MilliPROBE system is the first solution of its kind for biopharmaceutical manufacturing. It combines Millipore’s sample prep methodologies with Gen-Probe’s advanced nucleic acid technologies to deliver both speed and sensitivity in one microbial screening tool. The MilliPROBE system uses real-time transcription-mediated amplification (TMA) technology to detect targeted microbial contamination within hours compared to the days or weeks usually required to generate results using traditional culture-based technology.
The collaboration’s first MilliPROBE assay targets the bacterium Pseudomonas aeruginosa and is designed as an in-process, early warning system to provide faster, more effective detection of Pseudomonas aeruginosa in purified water used during drug production.